Our study results provide new ideas and directions for elucidating the mechanism and drug treatment of dopaminergic neuron death during the onset of PD, indicating that C9orf72 provides strong evidence supporting the potential of C9orf72 as a PD therapeutic target. This evidence concerns the gene C9orf72 and Parkinson disease.